The cost-effectiveness of patient-applied treatments for anogenital warts
P Williams, G von Krogh - International journal of STD & …, 2003 - journals.sagepub.com
A model was developed to estimate the cost-effectiveness of podophyllotoxin and imiquimod
for self-treatment of anogenital warts. The effectiveness endpoint was sustained clearance …
for self-treatment of anogenital warts. The effectiveness endpoint was sustained clearance …
Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts
CJN Lacey, RL Goodall, GR Tennvall, R Maw… - Sexually Transmitted …, 2003 - sti.bmj.com
Objectives: To evaluate the efficacy and cost effectiveness of self applied podophyllotoxin
0.5% solution and podophyllotoxin 0.15% cream, compared to clinic applied 25 …
0.5% solution and podophyllotoxin 0.15% cream, compared to clinic applied 25 …
[HTML][HTML] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …
The cost effectiveness of treatment of genital warts with podophyllotoxin
KC Mohanty - International journal of STD & AIDS, 1994 - journals.sagepub.com
The cost effectiveness of 25% podophyllin resin and 0.5% podophyllotoxin solution in the
treatment of genital warts in Genitourinary Medicine Clinic attenders was studied. Although …
treatment of genital warts in Genitourinary Medicine Clinic attenders was studied. Although …
Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts
P Komericki, M Akkilic-Materna… - Sexually transmitted …, 2011 - journals.lww.com
Background: Anogenital warts are a common sexually transmitted disease caused by
human papillomaviruses. Despite the fact, that imiquimod and podophyllotoxin represent …
human papillomaviruses. Despite the fact, that imiquimod and podophyllotoxin represent …
The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts.
PC Langley, SK Tyring, MH Smith - The American Journal of …, 1999 - europepmc.org
Objective External genital warts are one of the fastest growing sexually transmitted diseases
in the United States today. Two forms of therapy are available: provider-administered and …
in the United States today. Two forms of therapy are available: provider-administered and …
A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France
A Lafuma, J Monsonego… - … de Dermatologie et de …, 2003 - europepmc.org
[A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the
treatment of external anogenital warts in France]. - Abstract - Europe PMC Sign in | Create an …
treatment of external anogenital warts in France]. - Abstract - Europe PMC Sign in | Create an …
Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis
RN Werner, L Westfechtel, C Dressler… - Sexually Transmitted …, 2017 - sti.bmj.com
Background Anogenital warts (AGWs, condylomata acuminata) are among the most
common STIs and may severely impact quality of life (QoL). Available treatment options are …
common STIs and may severely impact quality of life (QoL). Available treatment options are …
A cost-effectiveness analysis of sinecatechins in the treatment of external genital warts
PC Langley - Journal of medical economics, 2010 - Taylor & Francis
Objective: To evaluate the cost-effectiveness and treatment-cost impact of sinecatechins
(Veregen) as first-line therapy against its principal comparator, imiquimod (Aldara), in the …
(Veregen) as first-line therapy against its principal comparator, imiquimod (Aldara), in the …
[HTML][HTML] A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study
Background: Studies comparing head-to-head treatment modalities for anogenital warts are
lacking. Aim: We sought to compare a short, 8-week course of imiquimod 5% cream to …
lacking. Aim: We sought to compare a short, 8-week course of imiquimod 5% cream to …
相关搜索
- podophyllotoxin in the treatment anogenital warts
- cost effectiveness anogenital warts
- cost effectiveness podophyllotoxin for the treatment
- podophyllin in the treatment genital warts
- immunocompetent patients anogenital warts
- evaluation of imiquimod anogenital warts
- healthcare provider anogenital warts
- economic evaluation genital warts
- podophyllotoxin solution genital warts
- papillomavirus vaccine anogenital warts
- efficacy and safety anogenital warts
- cost effectiveness intervention strategies
- meta analysis anogenital warts
- cost effectiveness genital warts
- safety of imiquimod anogenital warts
- podophyllotoxin cream genital warts